Go To Health!

Jonathan Marx, MBA

Details

Go To Health Media features health experts from around the world who bring evidence-based education from Western, alternative, and holistic practices. It is supported by our website and social media properties. We bring together the public (seeking relevant, reputable, and proven solutions to their healthcare needs) and healthcare providers and companies, trying to reach target audiences with quality information, services, and products. Follow-up connections with our experts are highlighted, so that we help our audiences achieve optimal health via reputable, up-to-date health information, services and products. Join us on our GoToHealth Podcast and our website at https://gotohealthmedia.com/video.

Recent Episodes

NOV 13, 2026
No Surgery, No Chemo for Colon Cancer? How Cancer Immunotherapy Changed Everything
No Surgery, No Chemo or Radiation for Colorectal Cancer? How one young patient avoided major surgery and an oncologist explains a new immunotherapy approach. Rectal cancer patient Dan Santonocito shares how he avoided surgery, chemotherapy and radiation after treatment with Jemperli (dostarlimab). He is joined by board-certified medical oncologist Meredith Pelster, MD, of SCRI Oncology Partners in Nashville, who specializes in gastrointestinal cancers as well as head and neck cancers, to explain how cancer immunotherapy is changing colorectal cancer care, who may be eligible, and what patients should ask their own oncology team. In this interview: Dan's rectal cancer diagnosis story as a young adult, why standard treatment often means surgery plus chemo and radiation, how Jemperli works as an immunotherapy, what complete response means, side effects and monitoring, and what this case means for the future of colon cancer and colorectal cancer treatment. This video is for education only and is not medical advice. Talk to your own doctor about cancer treatment options. Guests: Dan Santonocito - rectal cancer patient and Jemperli story Meredith Pelster, MD - Board-certified medical oncologist, SCRI Oncology Partners, Nashville - gastrointestinal and head and neck cancers About GoToHealth! - Evidence-based health interviews with experts from around the world on fitness, mental health, cancer, and wellness. More at https://gotohealthmedia.com/no-surgery-no-chemo-for-colon-cancer-how-cancer-immunotherapy-changed-everything/. Chapters: 00:00 Intro & Dan's Initial Symptoms 03:26 The Rising Rate of Rectal Cancer in Young Adults 05:49 Advocating for Alternatives: Finding Jemperli 08:09 Why Every Patient Needs Biomarker Testing (dMMR/MSI) 10:48 When Should You Get a Colonoscopy? 11:42 Dan's Cancer-Free Life Today 13:23 Standard Treatment vs. Immunotherapy 14:23 Final Advice on Patient Self-Advocacy If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! Learn more about your ad choices. Visit megaphone.fm/adchoices
19 MIN
NOV 10, 2026
Leg Pain at 28 Led To a Rare Cancer Diagnosis
For years, Sandra Miller's severe leg numbness and pain were dismissed by doctors as just "stress". In this powerful episode of Go to Health, Jonathan Marx sits down with Sandra and UCLA sarcoma specialist Dr. Noah Federman to discuss the rare condition that was actually causing her debilitating symptoms: a desmoid tumor. Key Insights: - Sandra spent four years fighting for a proper diagnosis after her symptoms—which began as tingling after a severe pelvic fracture—worsened into pain that prevented her from sleeping, walking, or driving. - Desmoid tumors are rare connective tissue growths (affecting only 1,000 to 1,500 people a year in the US) that primarily occur in young adults between the ages of 20 and 45. - Because of their extreme rarity, these tumors are incredibly difficult to diagnose and are frequently mistaken for common musculoskeletal issues, sprains, or even anxiety. - Treatment has drastically evolved over the last two decades; while surgery used to be the standard approach (often resulting in the tumor returning), the FDA recently approved Ogsiveo (nirogacestat), the first and only medication specifically designed to halt or slow the progression of these tumors. - Both guests stress that you are your own best advocate—if your symptoms persist without relief, demand further imaging, biopsies, or a referral to a multidisciplinary sarcoma center. ⏱️ Chapters: 00:00 Intro & Sandra's 4-Year Diagnostic Journey 03:49 What is a Sarcoma and a Desmoid Tumor? 04:51 Why Rare Tumors are So Hard to Diagnose 06:31 Ogsiveo: The New FDA-Approved Treatment Option 07:45 Demographics: Who Gets Desmoid Tumors? 08:21 Sandra's Life Today on Medication 09:35 The Crucial Importance of Patient Self-Advocacy If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! Learn more here: https://gotohealthmedia.com/leg-pain-at-28-led-to-a-rare-cancer-diagnosis/ Learn more about your ad choices. Visit megaphone.fm/adchoices
15 MIN
NOV 6, 2026
Ovarian Cancer Symptoms Women Ignore Until It's Too Late
Ovarian cancer symptoms are often dismissed as normal daily discomforts until the disease has already advanced. In this inspiring episode of Go to Health, Jonathan Marx sits down with Flower Miller, who was diagnosed with metastatic stage 4 ovarian cancer at just 41 years old. Key Insights: - Early symptoms of ovarian cancer can include fatigue, frequent urination, feeling full after only a few bites, and a hard, bloated belly. - Flower's cancer was discovered via a transvaginal ultrasound and CT scan after her primary care doctor pressed on her stomach and she noticed pain. - She attributes her survival to an aggressive treatment plan, enrolling in a two-year clinical trial for maintenance therapy, and building a collaborative relationship with a specialized gynecological oncologist. - Discovering she carried the BRCA1 gene mutation led Flour to undergo a prophylactic double mastectomy to prevent future breast cancer. ⏱️ Chapters: 00:00 Intro & Flour Miller's Story 01:05 Easily Missed Ovarian Cancer Symptoms 02:20 Almost Misdiagnosed with IBS 04:01 Processing a Stage 4 Cancer Diagnosis 05:40 Dose-Dense Chemotherapy & Surgeries 07:03 Self-Advocacy & Clinical Trials 09:40 The BRCA1 Gene & Family History 11:07 GSK's Our Way Forward Program 12:30 Tangible Hope for the Newly Diagnosed Learn more here: https://gotohealthmedia.com/ovarian-cancer-symptoms-women-ignore-until-its-too-late/ If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! Learn more about your ad choices. Visit megaphone.fm/adchoices
17 MIN
NOV 3, 2026
Why Your Hot Flashes Are Worse Than Your Friends’
Hot flashes are a common, disruptive symptom of menopause, but you do not have to suffer in silence. Over 2 million women enter menopause in the US each year, and nearly 50% experience moderate to severe hot flashes in their first year. In this episode of Go to Health, Jonathan Marx speaks with Dr. Diana Bitner, a board-certified OB/GYN and Menopause Society practitioner, about exactly what happens during a hot flash and how you can best talk to your doctor about finding relief. Dr. Bitner explains how the loss of estrogen triggers hyperactivity in the hypothalamus, causing your body to simulate a cooling event even in comfortable temperatures. She categorizes hot flashes from mild (a sensation of warmth) to severe (when warmth and sweating disrupt daily activities like sleep or work). Dr. Bitner recommends coming to your primary care provider or OB/GYN with a tracked list of symptoms. She also discusses LYNKUET, an FDA-approved, non-hormonal treatment option for moderate to severe hot flashes. Learn more here: https://gotohealthmedia.com/why-your-hot-flashes-are-worse-than-your-friends/ If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! Managing hot flashes during menopause is possible when you understand why they happen. Learn how to identify your symptoms. Nearly 50 percent of women experience moderate to severe hot flashes in their first year of menopause. In this episode of Go to Health, Jonathan Marx speaks with Dr. Diana Bitner, a board-certified OB/GYN, to explain how the loss of estrogen affects the hypothalamus. This hormonal shift triggers the body to simulate a cooling event, which can disrupt sleep and daily productivity. Dr. Bitner outlines the difference between mild and severe hot flashes while offering advice on preparing for your next doctor visit. By keeping a tracked list of your symptoms, you can better communicate your needs to your primary care provider. The conversation also covers current FDA-approved non-hormonal treatment options for women seeking relief from these intense temperature fluctuations. If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! 0:00 Understanding Menopause and Hot Flashes 1:00 The Science Behind the Hot Flash 1:51 Defining Mild, Moderate, and Severe Symptoms 3:53 Exploring Non-Hormonal Treatment Options2476/5000 100 Suggestions Managing hot flashes during menopause is possible when you understand why they happen. Learn how to identify your symptoms. Nearly 50 percent of women experience moderate to severe hot flashes in their first year of menopause. In this episode of Go to Health, Jonathan Marx speaks with Dr. Diana Bitner, a board-certified OB/GYN , to explain how the loss of estrogen affects the hypothalamus. This hormonal shift triggers the body to simulate a cooling event, which can disrupt sleep and daily productivity. Dr. Bitner outlines the difference between mild and severe hot flashes while offering advice on preparing for your next doctor visit. By keeping a tracked list of your symptoms, you can better communicate your needs to your primary care provider. The conversation also covers current FDA-approved non-hormonal treatment options for women seeking relief from these intense temperature fluctuations. If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! Learn more about your ad choices. Visit megaphone.fm/adchoices
10 MIN
OCT 30, 2026
You Flu Shot Could be Better than You Think with the NEW mRNA Vaccine
A new mRNA flu vaccine could offer adults 50 and older a powerful new way to protect themselves against serious illness this season. In this episode of Go to Health, Jonathan Marx speaks with Bishoy Rizkalla, PhD, Vice President of Medical Affairs for Infectious Diseases at Moderna, to discuss how this newly FDA-approved vaccine works and why it is a game-changer for public health. Key Insights: - Unlike traditional vaccines that rely on a 70-year-old egg-based manufacturing process, this new vaccine uses mRNA technology to deliver temporary instructions that train your immune system to detect and defeat the virus. - In massive clinical studies involving over 40,000 individuals, the mRNA flu vaccine was shown to be approximately 27% more effective than traditional flu vaccines in preventing flu illness. - As we age, our immune systems weaken and chronic conditions make it harder to recover from infections; in fact, the CDC reports that nine out of ten flu-related deaths occur in adults 65 and older. - Remember the saying "Flu before Boo"—experts highly recommend getting your seasonal flu vaccination before Halloween. Find the Moderna mRNA vaccine near you: https://products.modernatx.com/finder Learn more from GoToHealth: https://gotohealthmedia.com/your-flu-shot-could-be-better-than-you-think-with-the-new-mrna-vaccine/ If you enjoyed this episode of Go to Health, please give us a thumbs up or a 5-star rating on YouTube, Apple, Spotify, or wherever you are listening! Learn more about your ad choices. Visit megaphone.fm/adchoices
10 MIN